Daphné Morel
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Chromatin Remodeling and Cancer 4
- Heat shock proteins research 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Sophie Postel‐Vinay (6 shared papers)Sandrine Aspeslagh (2 shared papers)Geneviève Almouzni (3 shared papers)Daniel Jeffery (1 shared paper)Jean‐Charles Soria (4 shared papers)Loïc Verlingue (3 shared papers)François‐Xavier Danlos (1 shared paper)Éric Deutsch (9 shared papers)
- Journals
- European Journal of Cancer (3 papers)Annals of Oncology (3 papers)Clinical Cancer Research (1 paper)Advances in Therapy (1 paper)International review of cell and molecular biology (1 paper)
- Partner nations
- FranceUnited StatesChile
In The Last Decade
Daphné Morel
20 papers receiving 663 citations
Daphné Morel's Hit Papers
Peers
Comparison fields: 5 of 79
- Health Informatics 10
- Oncology 185
- Molecular Biology 420
- Cancer Research 82
- Immunology 92
Countries citing papers authored by Daphné Morel
This map shows the geographic impact of Daphné Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphné Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphné Morel more than expected).
Fields of papers citing papers by Daphné Morel
This network shows the impact of papers produced by Daphné Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphné Morel. The network helps show where Daphné Morel may publish in the future.
Co-authors
The 25 scholars most cited alongside Daphné Morel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise Hit paper breakdown → | 2019 | 320 |
| 2 | 2021 | 91 | |
| 3 | 2018 | 68 | |
| 4 | 2016 | 62 | |
| 5 | 2019 | 25 | |
| 6 | 2023 | 23 | |
| 7 | 2024 | 20 | |
| 8 | 2022 | 19 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 8 | |
| 11 | 2022 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2009 | 1 |
About Daphné Morel
Daphné Morel is a scholar working on Oncology, Molecular Biology, Surgery, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 21 papers that have together received 672 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Chromatin Remodeling and Cancer (4 papers), Cancer Genomics and Diagnostics (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Effects of Radiation Exposure (2 papers), Head and Neck Cancer Studies (1 paper), Heat shock proteins research (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Health Informatics (10 citations), Oncology (185 citations), Molecular Biology (420 citations), Cancer Research (82 citations) and Immunology (92 citations). Daphné Morel has collaborated with scholars based in France, United States and Chile. Frequent co-authors include Sophie Postel‐Vinay, Sandrine Aspeslagh, Geneviève Almouzni, Daniel Jeffery, Jean‐Charles Soria, Loïc Verlingue, François‐Xavier Danlos, Éric Deutsch, Andreï Zinovyev and Aurélien Marabelle. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Clinical Cancer Research, Advances in Therapy and International review of cell and molecular biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.